Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CL vs MRNA✓SelectedUSD · MRNACL vs MRNA performance historyLatest closeAs of-1.99%11/19
Stock and ETF performance explorer

CL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+40.7%
MRNA return
-25.6%
Excess return
+66.3%
Maximum drawdown
-29.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.0%+1.3%-3.3%-2.0%
7D-1.0%-13.8%+12.8%-1.0%
30D+2.5%-17.7%+20.1%+2.5%
3M+7.2%+14.3%-7.1%+7.2%
6M+8.9%+336.0%-327.1%+8.4%
YTD+25.5%+575.9%-550.4%+24.2%
1Y+26.4%+724.4%-697.9%+24.7%
3Y+37.4%+160.8%-123.4%+36.3%
All+40.7%-25.6%+66.3%+38.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling